Value creation starts with a simple equation:

World-Leading Science + Driven Entrepreneurs

= Value Creation

Our portfolio includes investments across all emerging disciplines, such as autonomous systems/AI, quantum technology, mobility, sustainable energy, genomics, synthetic biology, life sciences, and blockchain. This leads to a diversified portfolio of companies with category-creating potential.

Bohr QT

Professor Maria Spiropulu. Quantum security at the speed of light.

Port Therapeutics

Professor Mikhail Shapiro. Ultrasound-enabled drug discovery.

Currently in stealth

DNATwo

Professor J. Campbell & B. Stoltz. Novel cancer therapeutics targeting DNA repair and replication.


Currently in stealth

HEPT

Professor Ali Hajimiri. Hybrid electronic, photonic technology.

Currently in stealth

Flion

Professor Kimberly See. Sustainable energy storage from abundant eco-materials.

Currently in stealth

Tera AI

Tony Zhang, PhD. Superhuman reasoning of the physical world.

Currently in stealth

Receptive Bio

Professor Viviana Gradinaru. Neuroscience target discovery.

Currently in stealth

3Laws Robotics

Professor Aaron Ames. Autonomous and robotic systems that do no harm.

Palamedrix

Acquired by Somalogic (NASDAQ: SLGC). Intra-cellular interrogation at analyte resolution.

Aizen Therapeutics

Professor David Van Valen. AI-enabled drug discovery.

Pinc

Professor Alireza Mirandi. Full spectrum, tunable, non-linear optics.

Asymptote Bio

Professor Michael Elowitz. Synthetic Biology inspired therapeutics.

Currently in stealth

Switch Therapeutics

Professor Bill Goddard. Next-generation RNAi therapies for unmet diseases.

ZeoDAC

Professor Mark Davis. Next-generation carbon capture and use.

Soaring Technologies

Professor Mory Gharib. Drone technology for advanced military and logistics. American Made.